To determine the role of S100A7 in the activation of ESCC signaling pathways, we constructed KYSE‐30 and KYSE‐150 cell lines that stably overexpressed S100A7 (Figure 3A). Here, S100A7 is linked to esophageal squamous cell carcinoma.